Echo Real Estate Capital Acquires Carmel, IN Medical Office Building

Echo Real Estate Capital Acquires Carmel, IN Medical Office Building

Echo Real Estate Capital, Inc. announced it has acquired a 33,000-square-foot medical office building (MOB) located in the Penn Mark Plaza office park in Carmel, Indiana.  The MOB is occupied by Ascension-St. Vincent, Turkle & Associates Center for Plastic Surgery and Abram’s Eyecare – a third-generation practice with three locations.  Echo Real Estate Capital is a full-service real estate investment and development firm with a national platform specializing in build-to-suit development, value-add investments, sale/leasebacks and capital markets advisory services for healthcare providers, national retailers, industrial manufacturing and distribution companies and general... Read More »
BayCare Health Acquires 49-Physician Health Clinic

BayCare Health Acquires 49-Physician Health Clinic

Clearwater, Florida-based BayCare Health System has announced that it is acquiring Gessler Clinic, a physician-owned medical group, effective December 2, 2023. Gessler Clinic is based in Winter Haven, Florida. The clinic has 49 physicians covering 24 specialties, according to its website.  BayCare Health is a not-for-profit healthcare system that operates 16 hospitals and hundreds of outpatient locations throughout the Tampa Bay and central Florida regions.  Most of the Gessler Clinic providers and team members will join BayCare, including BayCare Medical Group, Tampa Bay’s leading multi-specialty group. Financial terms of the deal were not disclosed.  According to data... Read More »
Thrive Precision Health Announces Acquisition of Heal Diabetes

Thrive Precision Health Announces Acquisition of Heal Diabetes

Thrive Precision Health announced on November 17 that it has entered into an agreement to acquire Heal Diabetes, which operates two diabetes clinics in Hawaii. The clinics are located in Honolulu and Waianae and have treated more than 350 patients in 2023.  Thrive Precision Health, formerly Thrive Global Biosafety and China New Energy Group Company, is building a global diabetes care powerhouse. The company is starting or acquiring healthcare clinics specializing in diabetes care and bringing in cutting-edge technologies to to improve the quality of care provided at the clinic.  Thrive Precision Health, alongside its subsidiary Thrive Testing and Biosafety Inc., will acquire the two... Read More »
ArchiMed Expands Clinical Research Organization Portfolio 

ArchiMed Expands Clinical Research Organization Portfolio 

ArchiMed announced it has acquired two clinical contract research organizations (CRO): Port Jefferson, New York-based Symbio, LLC and Proinnovera GmbH, in Munster, Germany.   According to data captured in the LevinPro HC database, this transaction marks the 37th CRO acquisition of the year. Between January 1, 2022, and November 17, 2022, there were also 37 CRO transactions announced, showing a healthy and stable CRO market.  Symbio offers expertise in proof-of-concept, medical devices and Phase 1 – Phase 4 clinical studies and has completed more than 200 clinical studies to date. Proinnovera was founded in 1997. It serves more than 100,000 patients across more than 4,500... Read More »
Bharath Home Medicare Acquires Indian Company Strata Meditech

Bharath Home Medicare Acquires Indian Company Strata Meditech

Bharath Home Medicare announced on November 16 the successful acquisition of Strata Meditech, an India-based company offering occupational health management and annual medical checkups. Strata Meditech was founded in 2015 and serves more than 50 corporate clients.  Bharath Home Medicare provides holistic home health care services to all age groups with electronic medical records. Their services include patient support, vaccinations, physiotherapy, speech therapy, diagnostics and medical equipment rental and sales.  The transaction was completed on November 10, 2023. Strata’s operations will be overseen by Varadharajan K. as Director and Rajasekharan N.S. as Chief Business... Read More »
Ajinomoto Acquires Forge Biologics for $620 Million

Ajinomoto Acquires Forge Biologics for $620 Million

Ajinomoto Co., Inc. and Forge Biologics announced on November 13 that they have entered into a definitive agreement by which Ajinomoto will acquire Forge Biologics in an all-cash deal for $620 million.  Forge Biologics is a viral vector and plasmid contract development and manufacturing organization (CDMO) and clinical-stage therapeutics company, enabling access to potentially life-changing gene therapies by bringing them from concept to reality. All development and manufacturing is done at the Hearth, Forge Biologics’ 200,000 square-foot custom-designed cGMP facility in Columbus, Ohio, where the CDMO has more than 300 employees.  Ajinomoto Co. is a global manufacturer of... Read More »